BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Virol. Mar 25, 2026; 15(1): 116055
Published online Mar 25, 2026. doi: 10.5501/wjv.v15.i1.116055
Figure 2
Figure 2 From elite neutralisers, B-cells producing broad neutralising antibodies are isolated, and antibody genes are extracted and cloned into expression vectors for production. Applications include: (1) Passive immunisation via bnAb infusions for immediate viral control; (2) Germline targeting vaccines designed to activate bnAb precursor B-cells; and (3) Gene therapy delivering bnAb genes for long-term endogenous production.


Write to the Help Desk